It was found that factor 1 derived from meningeal data and many of the genes correlated with this factor (CD69, granzyme A, IFNγ, LTβ, MHC class II, CCL2, and CCL5) efficiently discriminate two clusters of samples, each comprising four MS cases. This evidence concerns the gene CD69 and myeloid sarcoma.